Altogether, these results suggest that miR-21 may contribute to NASH development not only through PPARα inhibition, ultimately inducing cell inflammation and fibrosis, but also by promoting liver steatosis and lipoapoptosis. The gene discussed is PPARA; the disease is fatty liver disease.